US IND Applications - 150
NDA 505(b)(1) Applications - 30
505(b)(2) Applications - 40
FDA Meetings Including All Types (A,B, and C) - 100
Served As US Agent - 54
0
+
Orphan Drug Designation Requests
0
+
Pediatric Waivers and iPSP
0
+
Special Protocol Assessments (SPAs)
0
+
Breakthrough Therapy Designation Requests
0
+
Small Business Waivers
0
+
Canadian CTAs
0
+
DMF Applications
0
+
Generics (ANDA) Applications